What are the prospects for controlling hepatitis C?

PLoS Medicine

Volumn 6, Issue 6, 2009, Pages

  Klenerman, Paul ^a   Fleming, Vicki ^a   Barnes, Ellie ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEIC ACID;

GENOTYPE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; IMMUNE RESPONSE; INFECTION CONTROL; INFLUENZA; INFLUENZA VIRUS A; MICROBIAL DIVERSITY; NUCLEIC ACID ANALYSIS; NUCLEOTIDE SEQUENCE; REVIEW; VIRUS GENOME;

GENETIC VARIATION; GENOME, VIRAL; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VACCINES; HEPATITIS B VIRUS; HEPATITIS C; HUMANS; RNA, VIRAL; WORLD HEALTH;

EID: 67650236561     PISSN: 15491277     EISSN: 15491676     Source Type: Journal    
DOI: 10.1371/journal.pmed.1000096     Document Type: Review

References (19)

1. World Hepatitis Alliance (2009) World Hepatitis Day. Available: http://www.worldhepatitisday.org/. Accessed 11 May 2009.
2. Klenerman P, Kim A (2007) HCV-HIV coinfection: Simple messages from a complex disease. PLoS Med 4: e240. doi:10.1371/journal.pmed.0040240.
3. Houghton M (2009) Discovery of the hepatitis C virus. Liver Int 29(Suppl 1): 82-88.
4. Wakita T, Pietschmann T, Kato T, Date T, Miyamoto M, et al. (2005) Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat Med 11: 791-796.
5. Simmonds P (2004) Genetic diversity and evolution of hepatitis C virus - 15 years on. J Gen Virol 85: 3173-3188.
6. Pybus OG, Charleston MA, Gupta S, Rambaut A, Holmes EC, et al. (2001) The epidemic behavior of the hepatitis C virus. Science 292: 2323-2325.
7. Kuiken C, Simmonds P (2009) Nomenclature and numbering of the hepatitis C virus. Methods Mol Biol 510: 33-53.
8. Pybus OG, Barnes E, Taggart R, Lemey P, Markov PV, et al. (2009) Genetic history of hepatitis C virus in East Asia. J Virol 83: 1071-1082.
9. Zeuzem S, Berg T, Moeller B, Hinrichsen H, Mauss S, et al. (2009) Expert opinion on the treatment of patients with chronic hepatitis C. J Viral Hepat 16: 75-90.
10. Torres-Puente M, Cuevas JM, Jimenez-Hernandez N, Bracho MA, Garcia-Robles I, et al. (2008) Genetic variability in hepatitis C virus and its role in antiviral treatment response. J Viral Hepat 15: 188-199.
11. Drexler JF, Kupfer B, Petersen N, Grotto RMT, Rodrigues SMC, et al. (2009) A novel diagnostic target in the hepatitis C virus genome. PLoS Med 6: e1000031. doi:10.1371/journal.pmed.1000031.
12. Nagamine K, Hase T, Notomi T (2002) Accelerated reaction by loop-mediated isothermal amplification using loop primers. Mol Cell Probes 16: 223-229.
13. Thompson AJ, McHutchison JG (2009) Review article: Investigational agents for chronic hepatitis C. Aliment Pharmacol Ther 29: 689-705.
14. Thimme R, Neumann-Haefelin C, Boettler T, Blum HE (2008) Adaptive immune responses to hepatitis C virus: From viral immunobiology to a vaccine. Biol Chem 389: 457-467.
15. Schulze Zur Wiesch J, Lauer GM, Timm J, Kuntzen T, Neukamm M, et al. (2007) Immunologic evidence for lack of heterologous protection following resolution of HCV in patients with non-genotype 1 infection. Blood 110: 1559-1569.
16. Gaudieri S, Rauch A, Pfafferott K, Barnes E, Cheng W, et al. (2009) Hepatitis C virus drug resistance and immune-driven adaptations: Relevance to new antiviral therapy. Hepatology 49: 1069-1082.
17. Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, et al. (2008) The influenza virus resource at the National Center for Biotechnology Information. J Virol 82: 596-601.
18. Combet C, Penin F, Geourjon C, Deleage G (2004) HCVDB: Hepatitis C virus sequences database. Appl Bioinformatics 3: 237-240.
19. Division of AIDS, National Institute of Allergy and Infectious Diseases (2009) HIV databases. Available: http://www.hiv.lanl.gov/. Accessed 11 May 2009.